Mary K Hayden, Kimberly E Hanson, Janet A Englund, Francesca Lee, Mark J Lee, Mark Loeb, Daniel J Morgan, Robin Patel, Abdallah El Alayli, Ibrahim K El Mikati, Shahnaz Sultan, Yngve Falck-Ytter, Razan Mansour, Justin Z Amarin, Rebecca L Morgan, M Hassan Murad, Payal Patel, Adarsh Bhimraj, Reem A Mustafa
BACKGROUND: Immunoassays designed to detect SARS-CoV-2 protein antigens (Ag) are commonly used to diagnose COVID-19. The most widely used tests are lateral flow assays that generate results in approximately 15 minutes for diagnosis at the point-of-care. Higher throughput, laboratory-based SARS-CoV-2 Ag assays have also been developed. The number of commercially available SARS-CoV-2 Ag detection tests has increased rapidly, as has the COVID-19 diagnostic literature. The Infectious Diseases Society of America (IDSA) convened an expert panel to perform a systematic review of the literature and develop best practice guidance related to SARS-CoV-2 Ag testing...
January 26, 2023: Clinical Infectious Diseases